These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23486419)

  • 21. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
    Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL
    Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further evaluation of a multiplex PCR for differentiation of Salmonella paratyphi A from other salmonellae.
    Teh CS; Chua KH; Puthucheary SD; Thong KL
    Jpn J Infect Dis; 2008 Jul; 61(4):313-4. PubMed ID: 18653978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR is an optimal target for the design of specific PCR assays for salmonella enterica serotypes Typhi and Paratyphi A.
    Fabre L; Le Hello S; Roux C; Issenhuth-Jeanjean S; Weill FX
    PLoS Negl Trop Dis; 2014; 8(1):e2671. PubMed ID: 24498453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of Salmonella enterica subspecies enterica serovar Paratyphi B dT+, or Salmonella Java, from Indonesia and alteration of the d-tartrate fermentation phenotype by disrupting the ORF STM 3356.
    Han KH; Choi SY; Lee JH; Lee H; Shin EH; Agtini MD; von Seidlein L; Ochiai RL; Clemens JD; Wain J; Hahn JS; Lee BK; Song M; Chun J; Kim DW
    J Med Microbiol; 2006 Dec; 55(Pt 12):1661-1665. PubMed ID: 17108269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 23-year retrospective investigation of Salmonella Typhi and Salmonella Paratyphi isolated in a tertiary Kathmandu hospital.
    Zellweger RM; Basnyat B; Shrestha P; Prajapati KG; Dongol S; Sharma PK; Koirala S; Darton TC; Dolecek C; Thompson CN; Thwaites GE; Baker SG; Karkey A
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006051. PubMed ID: 29176850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High level ciprofloxacin resistance in Salmonella enterica isolated from blood.
    Raveendran R; Wattal C; Sharma A; Oberoi JK; Prasad KJ; Datta S
    Indian J Med Microbiol; 2008; 26(1):50-3. PubMed ID: 18227598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan.
    Qamar FN; Azmatullah A; Kazi AM; Khan E; Zaidi AK
    J Infect Dev Ctries; 2014 Aug; 8(8):981-6. PubMed ID: 25116662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuated
    Liu Q; Li P; Luo H; Curtiss R; Kong Q
    Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salmonella Typhi and Paratyphi A infections in Cambodian children, 2012-2016.
    Kheng C; Meas V; Pen S; Sar P; Turner P
    Int J Infect Dis; 2020 Aug; 97():334-336. PubMed ID: 32569838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in Host Cell Invasion and Salmonella Pathogenicity Island 1 Expression between Salmonella enterica Serovar Paratyphi A and Nontyphoidal S. Typhimurium.
    Elhadad D; Desai P; Grassl GA; McClelland M; Rahav G; Gal-Mor O
    Infect Immun; 2016 Apr; 84(4):1150-1165. PubMed ID: 26857569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi.
    Day MR; Doumith M; Do Nascimento V; Nair S; Ashton PM; Jenkins C; Dallman TJ; Stevens FJ; Freedman J; Hopkins KL; Woodford N; De Pinna EM; Godbole G
    J Antimicrob Chemother; 2018 Feb; 73(2):365-372. PubMed ID: 29216342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
    Morita M; Ito K; Hirose K; Takahashi H; Shimuta K; Terajima J; Ohnishi M; Harada M; Matsuzaki M; Watanabe H; Izumiya H
    Microbiol Immunol; 2006; 50(9):707-11. PubMed ID: 16985292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.
    Gat O; Galen JE; Tennant S; Simon R; Blackwelder WC; Silverman DJ; Pasetti MF; Levine MM
    PLoS Negl Trop Dis; 2011 Nov; 5(11):e1373. PubMed ID: 22069504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vertical transmission of Salmonella paratyphi A.
    Raveendran R; Wattal C; Sharma A; Kler N; Garg P; Gujral K; Khera N
    Indian J Pediatr; 2007 Aug; 74(8):784-6. PubMed ID: 17785907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of pathogenic and resistant genome repertoire reveals two clonal lines in Salmonella enterica subsp. enterica serovar Paratyphi B (+)-tartrate positive.
    Huehn S; Helmuth R; Bunge C; Guerra B; Junker E; Davies RH; Wattiau P; van Pelt W; Malorny B
    Foodborne Pathog Dis; 2009 May; 6(4):431-43. PubMed ID: 19292689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening method for Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones by PCR-restriction fragment length polymorphism.
    Hirose K; Tamura K; Watanabe H
    Microbiol Immunol; 2003; 47(2):161-5. PubMed ID: 12680720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.
    Gibani MM; Jin C; Shrestha S; Moore M; Norman L; Voysey M; Jones E; Blackwell L; Thomaides-Brears H; Hill J; Blohmke CJ; Dobinson HC; Baker P; Jones C; Campbell D; Mujadidi YF; Plested E; Preciado-Llanes L; Napolitani G; Simmons A; Gordon MA; Angus B; Darton TC; Cerundulo V; Pollard AJ
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008783. PubMed ID: 33079959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.